Abstract |
XRCC4 plays a crucial role in the non-homologous end joining pathway that maintains genome stability. In this two-stage case-control study with 1,764 non-BRCA1/2 breast cancer patients and 1,623 cancer-free controls, we investigated the contribution of genetic variants of XRCC4 to breast cancer susceptibility in Chinese women. We identified a recessive missense variant, rs3734091 (c.739G>T, p.Ala247Ser), of XRCC4 that was significantly associated with an increased risk of breast cancer (odds ratio [OR] = 3.92, P = 0.007), particularly with the risk of developing triple-negative breast cancer (OR = 18.65, P < 0.0001). This p.Ala247Ser variant disturbed the nuclear localization of XRCC4 in cells homozygous for the rs3734091-T allele but not in heterozygous cells at both the cellular and tissue levels. In heterozygous cells, wild-type XRCC4 facilitated the nuclear localization of the XRCC4A247S mutant, thus compensating for the impaired localization of XRCC4A247S. This provided a biological mechanism by which rs3734091 conferred an increased susceptibility to non-BRCA1/2 breast cancer exclusively under a recessive model. Further functional analyses revealed that p.Ala247Ser impaired the DNA damage repair capacity and ultimately perturbed genomic stability. Taken together, our findings document the role of XRCC4 in non-BRCA1/2 breast cancer predisposition and reveal its underlying biological mechanism of action.
|
Authors | Min He, Xin Hu, Li Chen, A-Yong Cao, Ke-Da Yu, Ting-Yan Shi, Xia-Ying Kuang, Wen-Biao Shi, Hong Ling, Shan Li, Feng Qiao, Ling Yao, Qingyi Wei, Gen-Hong Di, Zhi-Ming Shao |
Journal | Oncotarget
(Oncotarget)
Vol. 5
Issue 23
Pg. 12218-32
(Dec 15 2014)
ISSN: 1949-2553 [Electronic] United States |
PMID | 25360583
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA-Binding Proteins
- RNA, Small Interfering
- XRCC4 protein, human
|
Topics |
- Asian People
(genetics)
- Blotting, Western
- Breast Neoplasms
(genetics, metabolism)
- Case-Control Studies
- Cell Nucleus
(metabolism)
- Comet Assay
- DNA Damage
- DNA-Binding Proteins
(genetics, metabolism)
- Female
- Fluorescent Antibody Technique
- Genes, BRCA1
- Genes, BRCA2
- Genetic Predisposition to Disease
(genetics)
- Genotype
- Humans
- Immunohistochemistry
- Immunoprecipitation
- Polymerase Chain Reaction
- Protein Transport
- RNA, Small Interfering
|